Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

HealthCap

Founders Bjorn Odlander

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 121
Average round size
info
The average size of a deal this fund participated in
$30M
Portfolio companies 70
Rounds per year 4.32
Lead investments 11
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.42
Exits 31
Key employees 6
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
Summary

HealthCap is the famous VC, which was founded in 1996. The main department of described VC is located in the Stockholm. The venture was found in Europe in Sweden.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the HealthCap, startups are often financed by HBM Healthcare Investments AG, Alta Partners, Johnson & Johnson Development Corporation. The meaningful sponsors for the fund in investment in the same round are Sofinnova Partners, Industrifonden, Apax Partners. In the next rounds fund is usually obtained by Industrifonden, HBM Healthcare Investments AG, Sofinnova Partners.

Opposing the other organizations, this HealthCap works on 2 percentage points more the average amount of lead investments. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2005. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 3 percentage points more often commits exit comparing to other organizations. When the investment is from HealthCap the average startup value is 5-10 millions dollars. The increased amount of exits for fund were in 2015.

We also calculated 6 valuable employees in our database.

For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Algeta, Pulmonx, Fusion Pharmaceuticals We can highlight the next thriving fund investment areas, such as Manufacturing, Health Care. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 3 or 4 of the founder, the chance for it to get the investment is meager.

Read more

Funds with similar focus

Funds from Sweden
Funds with similar focus located in Sweden:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ADCendo

Biotechnology
$18M29 May 2024 Copenhagen, Capital Region of Denmark, Denmark

SynOx Therapeutics

$75M22 Apr 2024 Dublin, Dublin, Ireland

Aro Biotherapeutics

Biotechnology
Medical
Pharmaceutical
Therapeutics
$41M28 Nov 2023 Philadelphia, Pennsylvania, United States

Rampart Bioscience

Biopharma
Biotechnology
Medical
Therapeutics
$85M24 Oct 2023 La Jolla, California, United States

HelloBetter

Health Care
$8M03 May 2023 Berlin, Berlin, Germany

ADCendo

Biotechnology
$36M04 Apr 2023 Copenhagen, Capital Region of Denmark, Denmark

Hemab

Biotechnology
Life Science
Pharmaceutical
$135M21 Feb 2023 Copenhagen, Capital Region of Denmark, Denmark

Carisma Therapeutics

Biotechnology
Health Care
Life Science
Medical
Therapeutics
$30M21 Sep 2022 Philadelphia, Pennsylvania, United States

Pretzel Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
$72M12 Sep 2022 Waltham, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent HealthCap?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 121
Average round size 30M
Rounds per year 4.32
Peak activity year 2005
Lead investments 11
Follow on index 0.42
Exits 31
Group Appearance index 0.95

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

ADCendo

Biotechnology
$18M29 May 2024 Copenhagen, Capital Region of Denmark, Denmark

SynOx Therapeutics

$75M22 Apr 2024 Dublin, Dublin, Ireland

Aro Biotherapeutics

Biotechnology
Medical
Pharmaceutical
Therapeutics
$41M28 Nov 2023 Philadelphia, Pennsylvania, United States

Rampart Bioscience

Biopharma
Biotechnology
Medical
Therapeutics
$85M24 Oct 2023 La Jolla, California, United States

HelloBetter

Health Care
$8M03 May 2023 Berlin, Berlin, Germany

ADCendo

Biotechnology
$36M04 Apr 2023 Copenhagen, Capital Region of Denmark, Denmark

Hemab

Biotechnology
Life Science
Pharmaceutical
$135M21 Feb 2023 Copenhagen, Capital Region of Denmark, Denmark

Carisma Therapeutics

Biotechnology
Health Care
Life Science
Medical
Therapeutics
$30M21 Sep 2022 Philadelphia, Pennsylvania, United States

Pretzel Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
$72M12 Sep 2022 Waltham, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: